AstraZeneca Pharma gets CDSCO nod to import Calquence 100 mg tablets for additional indication

Shares of Astrazeneca Pharma India Ltd ended at ₹8,291.50, up by ₹235.70, or 2.93%, on the BSE.

Shares of Astrazeneca Pharma India Ltd ended at ₹8,291.50, up by ₹235.70, or 2.93%, on the BSE.

Swiggy co-founder Nandan Reddy has stepped down from the board, as the company announced leadership changes including new executive director appointments, signalling a transition into its next phase of growth.

Shares of Adani Green Energy Ltd ended at ₹1,085.30, up by ₹40.75, or 3.90%, on the BSE.

Amit Anwani, Research Analyst at PL Capital says India’s localisation push in nuclear power will benefit domestic players like L&T and BHEL, though near-term Middle East risks and high valuations remain key concerns.

Dhiraj Agarwal, Managing Director, Ambit Investment Managers says India has entered a stock picker’s market with limited upside, steady inflows, and a themeless environment requiring disciplined investing.

Shapoorji Pallonji urges RBI to enforce Tata Sons listing, saying it will unlock value, as RBI weighs exempting or declassifying Tata Sons from NBFC rules

Indian households hold nearly $5 trillion worth of gold, and ASSOCHAM says unlocking even a small portion could significantly boost growth and support India’s economy.

Global investors turn cautious on India despite strong long term prospects, AI shift and fewer positive economic surprises cool sentiment and near term flows

Shareholders whose names appear as of the close of business hours on April 17, 2026, will be eligible to receive the interim dividend. Shares of Muthoot Finance Ltd ended at ₹3,578., up by ₹103.05, or 2.97%, on the BSE today,…

US stock futures hold near flat after a week of gains, as investors watch US Iran ceasefire talks, elevated oil prices and key US inflation and economic data due soon